Press Releases

 Filter by Provider

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today reported financial results for the third quarter ended September 30, 2025, and provided a corporate update.

BEDFORD, Texas, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (NASDAQ: LEGH), a leading manufacturer of community-focused manufactured homes, today announced entering into agreement to purchase the assets of AmeriCasa Solutions, LLC (“AmeriCasa Solutions”) and its proprietary sales management platform, FutureHomeX®. Legacy Housing also announced the appointment of Norman Newton, AmeriCasa’s Chief Executive Officer, as Legacy Housing’s new Chief Revenue Officer.

The Choiseul Institute has unveiled a new strategic note titled “Morocco 2035: From Economic Emergence to Strategic Influence” presented during the Choiseul Africa Business Forum held on November 4–5 in Rabat. Authored by Yasmina Asrarguis, Research Fellow at Princeton University, the paper provides an in-depth analysis of Morocco’s structural transformation since 1999 under the leadership of His Majesty King Mohammed VI, and outlines the nation’s development prospects toward 2035.

Releases Techno/EDM Music With an AI Domination Theme

The "United States Fair-Market Value Compensation Rates for Anesthesiologists KOLs" report has been added to ResearchAndMarkets.com's offering.

MultiSafepay, a leading European payment service provider, today announces that Rachelle Alexis Lim has been appointed as the new Chief Executive Officer (CEO) of MultiSafepay.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that multiple presentations featuring data from its LIVMARLI (maralixibat) and volixibat clinical programs will be shared during the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting®, taking place November 7-11, 2025, in Washington, D.C.

Trinity Place Holdings Inc. (OTC PINK: TPHS) (the "Company," "we," "our," or "us") today announced operating results for the third quarter ended September 30, 2025.

Tredegar Corporation (NYSE:TG, also the “Company” or “Tredegar”) today reported third quarter financial results for the period ended September 30, 2025.

PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will participate in the following upcoming investor conferences.

HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences:

Key Q3 2025 Highlights

Boron's inclusion on the 2025 U.S. Critical Minerals List reinforces 5E's role as America's next advanced-stage, domestic boron supplier

VANCOUVER, BC / ACCESS Newswire / November 7, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") will attend and exhibit at the 42nd Annual ANCI Assembly in Bologna, Italy, from November 12-14, 2025.

PLANO, TX / ACCESS Newswire / November 7, 2025 / BGSF, Inc. (NYSE:BGSF), a leading provider of workforce solutions for the specialized Property Management industry, today reported financial results for the third fiscal quarter ended September 28, 2025 and announced a stock buyback plan.

FAIRFIELD, NEW JERSEY / ACCESS Newswire / November 7, 2025 / Jerash Holdings (US), Inc. (Nasdaq:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, announced today that its board of directors approved the payment of a regular quarterly dividend of $0.05 per share on the Company's common stock. The dividend is payable on or about November 26, 2025 to the stockholders of record as of November 19, 2025.

Conference Call and Webcast set for Wednesday, November 12, 2025, at 4:15 PM Eastern time

New initiative in the Konkouré Delta builds on Senegal's success, advancing coastal restoration, biodiversity, and community resilience across West Africa.

Toronto, Ontario--(Newsfile Corp. - November 7, 2025) - AIP Asset Management, a leading Canadian alternative investment firm, is thrilled to...

One Equity Partners (“OEP”), a middle market private equity firm, today announced it has exited its investment in InfuCare Rx, Inc. (“InfuCare” or the “Company”) through a strategic founder-led equity buyback. Financial terms of the private transaction were not disclosed.

CrowdStrike (NASDAQ: CRWD) today announced that Fal.Con 2026 will take over the Mandalay Bay Resort in Las Vegas from August 31 – September 3, 2026, and launch the inaugural Day Zero Threat Summit to kick off Fal.Con week – marking the next evolution of the cybersecurity industry’s premier event.

KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of Autumnwood, Summerfield and Hayden, three new communities within the highly desirable Tivoli master plan in Modesto, California. Nestled among scenic orchards between the San Francisco Bay Area and the Sierra Nevada Mountains, Modesto features an ideal blend of small-town charm and a lively downtown scene, which includes a historic theater, boutique shopping and popular restaurants that offer everything from farm-to-table cuisine to international flavors. The new homes are designed for the way people live today, with popular features like modern kitchens overlooking large great rooms, expansive bedroom suites with walk-in closets, and ample storage space. The one- and two-story homes at Autumnwood and two-story homes at Hayden offer up to five bedrooms and three baths, while the one-story homes at Summerfield feature up to four bedrooms and two baths. Tivoli is walking distance to highly rated schools, and homeowners will appreciate the planned community amenities, which include walking paths, a park, children’s playground and new elementary school.

ClearBridge Energy Midstream Opportunity Fund Inc. (NYSE: EMO) announced today the unaudited statement of assets and liabilities, the net asset value and asset coverage ratio of the Fund as of October 31, 2025.

Strategy Inc (Nasdaq: STRF/STRC/STRK/STRD/MSTR) today announced the pricing of its initial public offering on November 6, 2025 of 7,750,000 shares of 10.00% Series A Perpetual Stream Preferred Stock (the “STRE Stock”), at a public offering price of €80.00 per share. The issuance and sale of the STRE Stock is scheduled to settle on November 13, 2025, subject to customary closing conditions.

Marcus & Millichap, Inc. (the “Company”, “Marcus & Millichap”, or “MMI”) (NYSE: MMI), a leading national real estate services firm specializing in commercial real estate investment sales, financing, research and advisory services, reported its third quarter financial results today.

Dechra, a global leader in veterinary specialty care, announced today its status as the newest Human-Animal Bond Certified Company. As a Human-Animal Bond Certified Company, Dechra has made a major commitment to supporting human-animal bond education for veterinary professionals, to training its own workforce on the science of the bond, and to supporting the research efforts of the Human-Animal Bond Research Institute (HABRI).

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced pivotal clinical validation results from the ALTUS study (NCT: 05064553). The prospective, head-to-head trial demonstrated that the company’s Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatocellular carcinoma (HCC) — the most common form of liver cancer — compared to the current standard of care.1,2

Global Partners LP (NYSE: GLP) (“Global” or the “Partnership”) today reported financial results for the third quarter ended September 30, 2025.

Align Capital Partners (“ACP”) recently completed the acquisition of Advantage Investigations (“Advantage” or the “Company”), a national insurance investigative services platform specializing in surveillance, research and related solutions, from MD Holdings. The new partnership will allow Advantage to further advance its growth strategy and technology roadmap, with CEO Shelly Kummings continuing in her role alongside ACP.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of Livdelzi® (seladelpar) for people living with primary biliary cholangitis (PBC). Findings support Livdelzi's consistent efficacy and safety outcomes in patients switching from obeticholic acid and positive impact on liver stiffness over 3 years. These findings were presented at The Liver Meeting® hosted by the American Association for the Study of Liver Diseases (AASLD) 2025 in Washington, D.C. (November 7–11).

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, today announced that President and Chief Executive Officer Rick Wilmer has been named to TIME's 2025 list of the 100 most influential leaders driving climate action in business.

Venu Holding Corporation (“VENU” or the “Company”) (NYSE American: VENU), the fan-founded, fan-owned, and artist-inspired company re-imagining premium live-music venues and hospitality destinations, announced today that its Founder, Chairman & Chief Executive Officer J.W. Roth has been named to Billboard’s 2025 Touring Power Players list.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies 2025 London Healthcare Conference.

Northern Trust, a leading provider of wealth management services, has taken top honors in three categories from Professional Wealth Management and The Banker magazines, publications of the Financial Times Group:

Kohl’s (NYSE: KSS) today is kicking off a month full of holiday savings for customers — starting with its Black Friday Early Access event, Nov. 7–9, and wrapping up with its extended Black Friday Week event from Nov. 23 - Nov. 29. From can’t-miss deals on gifts for the whole family to plenty of ways to earn coveted Kohl’s Cash®, shoppers can count on Kohl’s for all their holiday needs. Adding to the excitement, the all-new Kohl’s Holiday Quest kicks off today and invites everyone to play to win daily prizes and a chance at the $100,000 grand prize*.

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

Asbury Carbons, a leading global supplier of engineered solutions for carbon and graphite materials, announces an upcoming price adjustment on orders shipping on or after January 1, 2026.

nChroma Bio, a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, today announced new preclinical data presented at The Liver Meeting® 2025 of the American Association for the Study of Liver Diseases (AASLD). The results, including a Poster of Distinction, highlight the potential of the company’s lead candidate, CRMA-1001, to deliver a functional cure for chronic hepatitis B virus (HBV) through a novel epigenetic silencing approach.

Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity

RONAN, Mont., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), a leading platform technology that unleashes the power of water from air, today announced that it will report its third quarter 2025 results after market close on Thursday, November 13, 2025. Company management will host a conference call and Q&A session to discuss the results at 8:30 AM ET on Friday, November 14, 2025.

Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ET

BOSTON and LONDON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:

WEST PALM BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2026 third quarter results on Wednesday, November 19, 2025, at 9:00 a.m. ET. Dycom will issue a press release reporting its results earlier that morning.

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years and older compared to placebo

– Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation –

BRATISLAVA, Slovakia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity solutions, today announced a new major integration of its ESET PROTECT Platform with ConnectWise Asio, a modern remote monitoring and management (RMM) solution.

BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:

– Trial met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups –

The "Austria Fair-Market Value Compensation Rates for Endocrinology KOLs" report has been added to ResearchAndMarkets.com's offering.